South African short-term insurers: J.P. Morgan prefers Santam’s risk-adjusted value over OUTsurance’s higher-return but premium-priced franchise.

Overview

This comparative review assesses Santam and OUTsurance, two leading South African short-term insurers. J.P. Morgan considers OUTsurance the stronger operating franchise on returns and underwriting margins, but prefers Santam because its lower valuation, distribution breadth, prospective catalysts and faster path to profitability for its Lloyd’s platform offer better risk-adjusted value.

Core views

J.P. Morgan’s central conclusion is that Santam and OUTsurance are both high-quality South African short-term insurance franchises by global underwriting standards, but Santam offers the more attractive risk-adjusted proposition. The valuation gap is central: Santam trades at 9.5x forward P/E and 2.4x forward P/B, respectively 19% and 12% below its 10-year averages, whereas OUTsurance trades at 18x forward P/E and 6.5x P/B. J.P. Morgan therefore sees Santam as a cheaper entry point into a quality insurer with potential upside from business and capital-structure catalysts, while OUTsurance’s stronger operational profile is more fully reflected in its valuation. The report nevertheless finds OUTsurance superior on forecast operating economics. Over FY26–FY28, both insurers are projected to deliver positive gross written premium growth averaging about 9%, but OUTsurance is expected to achieve a 37% average ROE against Santam’s 26%, a 46% three-year average claims ratio against 61%, and a 20% underwriting margin against 8%. OUTsurance’s direct-to-consumer model is a key driver: it lowers acquisition costs relative to broker-dependent peers and supported an 86% combined ratio in the June 2026 results, versus 92% for Santam. Its South African business reported a 42% claims ratio, although group results were affected by catastrophe claims in Australia. Santam’s relative appeal rests on its ability to defend earnings and valuation in a less benign environment. J.P. Morgan sees it as better placed for soft pricing, low premium inflation and tougher competition from banks and insurtechs because of its broader multi-channel distribution and scale. The report also highlights Santam’s improving direct operation, MiWay, its property-book turnaround, Alternative Risk Transfer growth, more than 20% domestic market share, and a record of meeting its 5%–10% conventional-insurance underwriting-margin target. Santam’s growth has benefited partly from the broker channel, whose higher commissions remain a constraint, but its diversified product base and Sanlam backing support earnings quality. International expansion is the report’s principal differentiator between the companies’ new growth options. Santam’s Lloyd’s Syndicate 1918, launched in January 2026, is estimated to produce R1bn of FY26 gross written premium, or 2.1% of group GWP, compared with R801m and 2.0% for OUTsurance Ireland. Both ventures are expected to be loss-making in FY26: R500m for Syndicate 1918 and R489m for Ireland. However, J.P. Morgan views Santam’s loss as predominantly a timing and accounting effect, since premium recognition lags Lloyd’s market and fixed costs, while Ireland’s loss reflects a more conventional start-up scale-up curve. Syndicate 1918 is forecast to break even in 2027 with R2.2bn of committed capital, two years ahead of Ireland’s expected 2029 break-even and below Ireland’s roughly R3.5bn cumulative capital need. The global platform could also scale revenue more rapidly than a single-country operation. J.P. Morgan remains conservative in its valuations despite preferring Santam’s growth vector. It assigns little explicit value to either new venture because their current contribution is small, near-term reported earnings are distorted by transitory factors, and Ireland remains an earnings drag until FY29. This conservatism means the report treats Syndicate 1918 as upside optionality rather than as a separately valued earnings segment. Global benchmarking reinforces the quality of the South African market. In June 2026, Santam’s claims ratio was 58% and OUTsurance’s was 55%, both better than the cited global average of 62%; since 2018, Santam and OUTsurance averaged claims ratios of 59% and 54%, respectively. The comparison is more mixed on combined ratios: South African insurers averaged 92% versus a 91% global average since 2018, while OUTsurance’s direct model remains the stronger individual underwriting performer. J.P. Morgan therefore distinguishes between OUTsurance’s higher-return profit engine and Santam’s more compelling valuation efficiency, reflected in estimated normalized EPS growth of 12% for Santam and 9% for OUTsurance. For company-level valuation, J.P. Morgan rates Santam Overweight with a 54,270c Dec-28 price target, increased from 52,083c for Dec-27, and rates OUTsurance Neutral with a 10,082c Dec-28 target, increased from 9,047c for Dec-27. Santam’s target incorporates R45,851m for Conventional Insurance, R1,870m for Non-SA Insurance and R12,176m for Alternative Risk Transfer. OUTsurance’s target values South Africa at R88,510m and Youi Australia at R75,995m, with smaller contributions from Life Insurance and central/new-business development.

Analysis framework

J.P. Morgan compares the insurers’ three-year premium growth, earnings, ROE, claims ratios and underwriting margins; benchmarks their June 2026 and historical underwriting performance against global peers; assesses their distribution models and international expansion paths; then tests valuation through forward P/E, P/B, PEG and dividend-yield comparisons. For company targets, it discounts forecast underwriting and investment returns and separately applies a P/E multiple to Santam’s Alternative Risk Transfer business.

Methodology notes

• Valuation methodsDCF (Discounted Cash Flow)

  Absolute valuation based on discounting forecast underwriting results and investment returns.

  J.P. Morgan uses projected core insurance earnings and investment returns to derive each company’s price target, applying different costs of equity and long-term growth assumptions.

• Valuation methodsP/E and PEG Valuation

  Forward P/E, PEG and a 15x P/E valuation for Santam’s Alternative Risk Transfer business.

  The report compares each insurer’s earnings multiple against forecast EPS growth and peers, and values Santam’s Alternative Risk Transfer operation at 15x P/E.

• Industry AnalysisVolume-price decomposition

  Assessment of gross written premium growth, pricing conditions, premium inflation, distribution channels and underwriting margins.

  J.P. Morgan links growth and pricing conditions to claims, acquisition costs, margins and the ability of each insurer to defend profitability.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Santam Ltd (SNTJ.J, SNTSJ)

  Preferred covered insurer; J.P. Morgan rates it Overweight because its valuation is lower and its risk-adjusted catalysts are viewed more favorably.

  Strengths

  More than 20% South African P&C market share, diversified products, multi-channel distribution, MiWay improvement, Alternative Risk Transfer growth, a property-book turnaround and Syndicate 1918’s expected 2027 break-even.

  Weaknesses

  Lower forecast ROE and underwriting margin than OUTsurance; broker-channel growth carries higher commission costs; near-term syndicate results are distorted by timing and scaling.

  Comparison

  Trades at 9.5x forward P/E and 2.4x forward P/B versus OUTsurance at 18x and 6.5x, while OUTsurance is forecast to deliver higher returns.

  Risks

  Catastrophe losses, rand-driven claims inflation, weak economic growth, regulatory reform and potentially slower premium growth.

• OUTsurance Ltd (OUTJ.J, OUT SJ)

  Covered insurer rated Neutral; it has the stronger operating-return profile but trades close to J.P. Morgan’s target price.

  Strengths

  Direct-to-client model, superior underwriting margins, ROE above 30%, Youi market-share growth, South African commercial-lines growth and long-term Ireland expansion potential.

  Weaknesses

  Premium valuation, less diversified distribution than Santam, exposure to Australia-related catastrophe volatility and a longer-dated Ireland payback.

  Comparison

  Forecast average ROE of 37%, claims ratio of 46% and underwriting margin of 20% exceed Santam’s 26%, 61% and 8%, but its forward P/E is 18x versus Santam’s 9.5x.

  Risks

  Competitive pricing pressure, catastrophe claims, rand-related claims inflation and value erosion if Ireland requires substantial capital without succeeding.

Key data

• Santam forward P/E9.5x19% discount to its 10-year average; compared with 18x for OUTsurance.
• OUTsurance FY26–FY28 average ROE37%Compared with 26% for Santam.
• Santam FY26–FY28 average ROE26%Below OUTsurance’s 37% forecast average.
• OUTsurance FY26–FY28 underwriting margin20%Compared with 8% for Santam.
• Santam Syndicate 1918 FY26 GWPR1bnEquivalent to 2.1% of group GWP; expected to break even in 2027.
• OUTsurance Ireland FY26 GWPR801mEquivalent to 2.0% of group GWP; expected to break even in 2029.
• Syndicate 1918 committed capitalR2.2bnCompared with approximately R3.5bn cumulative capital required for OUTsurance Ireland.
• Santam price target54,270cOverweight rating; Dec-28 target, up from 52,083c for Dec-27.
• OUTsurance price target10,082cNeutral rating; Dec-28 target, up from 9,047c for Dec-27.

Impact & implications

The report argues that OUTsurance’s direct model, low claims ratio and high returns justify recognition as the stronger operating franchise, but that its higher valuation creates greater exposure to disappointment. Santam’s lower multiple, wider distribution, potential Sanlam-related structure catalyst and quicker international-profitability bridge make it J.P. Morgan’s preferred risk-adjusted holding.

Risks

• Severe weather and catastrophe events could raise claims for either insurer; Santam has greater South African geographic concentration, while OUTsurance has experienced volatility from Australian natural-peril claims.
• Softer pricing and low premium inflation could pressure margins as rate-cycle tailwinds fade.
• Competition from banks, insurtechs and insurance peers could increase pricing pressure, with J.P. Morgan viewing OUTsurance as less well placed to defend against it.
• A weaker rand could increase claims inflation and erode margins; a stronger rand can also dilute reported offshore growth and profits.
• OUTsurance Ireland’s longer payback and capital needs could erode shareholder value if the venture does not scale successfully.
• Santam faces risks from weak economic growth, regulatory reforms and potential slowing in premium growth.

What to watch

• The trajectory of weather and catastrophe losses, claims ratios and underwriting margins through 2027.
• Evidence that Santam can defend pricing and market share through its multi-channel distribution and MiWay direct business.
• Syndicate 1918 premium recognition, loss normalization, capital use and progress toward expected 2027 break-even.
• OUTsurance Ireland’s loss trajectory, capital deployment and progress toward its expected 2029 break-even.
• Youi’s volume-led growth, South African commercial-lines productivity and the effect of currency translation on OUTsurance’s offshore earnings.
• Potential Santam capital-return or corporate-structure actions, including a possible Sanlam minority buyout.